rethinkTHC Search
Menu
Study breakdown

Antidepressants may be less effective in adolescents who regularly use cannabis

Narrative ReviewPreliminary evidence
The takeaway

A narrative review concluded that antidepressants are likely less effective for adolescents with depression or anxiety who frequently use cannabis, based on overlapping and potentially competing mechanisms of action.

Psychiatrists, pediatricians, parents of teens on antidepressants who also use cannabis, and clinical trial designers.

Nearly all antidepressant trials excluded cannabis users

What the researchers found

Almost all randomized clinical trials of antidepressants excluded participants using cannabis or other drugs, so the expected course of therapy in cannabis users is unknown. Based on shared neurochemical pathways (serotonin, endocannabinoid, and other systems), the authors concluded it is reasonable to assume antidepressants are less effective in adolescents who use cannabis frequently.

Why it matters

Depression and anxiety are rising in adolescents, antidepressant prescriptions are increasing, and cannabis is the most commonly used illicit substance in this age group. Yet virtually no clinical trial has studied what happens when these are combined.

The numbers in context

No specific numerical outcomes reported. The review identified overlapping neurochemical pathways between antidepressants (targeting serotonin, norepinephrine) and cannabinoids (THC and CBD effects on endocannabinoid system).

How the study worked

Narrative literature review examining the mechanisms of action of antidepressants and cannabis, focusing on neurochemical overlaps and potential interactions relevant to adolescent treatment outcomes.

What this study cannot tell us

Narrative review based on mechanistic reasoning rather than clinical outcome data. The conclusion that antidepressants are "less effective" is an inference, not an established finding from head-to-head studies.

How to read the evidence

Narrative review based on mechanistic reasoning from pharmacology, without direct clinical evidence of the proposed interaction.

When this study was published

Published in 2022.

The bigger picture

This represents a major blind spot in psychiatric treatment. Millions of adolescents take antidepressants, many also use cannabis, yet the interaction between these has essentially never been studied in a clinical trial.

Questions still open

  • Should clinical trials of antidepressants in adolescents include cannabis users as a subgroup? Could CBD specifically interfere with or enhance antidepressant mechanisms?

Common questions

Does cannabis make antidepressants less effective?
No clinical trial has directly tested this, but this review argues it is likely based on overlapping neurochemical pathways between antidepressants and cannabinoids. The interaction remains unstudied in practice.
Have antidepressants been tested in teens who use cannabis?
Almost no randomized clinical trials of antidepressants included participants who used cannabis or other drugs, creating a major gap in knowledge about real-world treatment effectiveness.

Read the original research

Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.

International journal of environmental research and public health, 19(1)

Citation

Hen-Shoval, Danielle; Weller, Aron; Weizman, Abraham; Shoval, Gal. (2022). Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.. International journal of environmental research and public health, 19(1). https://doi.org/10.3390/ijerph19010523

Explore the wider topic